The estimated Net Worth of Robin Gene Seim is at least $7.58 Millón dollars as of 9 August 2021. Mr. Seim owns over 6,686 units of Omnicell stock worth over $1,294,210 and over the last 19 years he sold OMCL stock worth over $5,891,532. In addition, he makes $396,590 as Director at Omnicell.
Robin has made over 52 trades of the Omnicell stock since 2007, according to the Form 4 filled with the SEC. Most recently he sold 6,686 units of OMCL stock worth $1,013,598 on 9 August 2021.
The largest trade he's ever made was exercising 31,124 units of Omnicell stock on 29 March 2010 worth over $247,125. On average, Robin trades about 6,209 units every 58 days since 2006. As of 9 August 2021 he still owns at least 30,049 units of Omnicell stock.
You can see the complete history of Mr. Seim stock trades at the bottom of the page.
Robin Gene Seim is Director of the Company. Mr. Seim has served as a director of Omnicell since March 2019. Mr. Seim initially joined Omnicell in January 2006 and served in various financial and operational leadership roles, including Chief Financial Officer from January 2006 to August 2015 and President, Global Automation and Medication Adherence from March 2016 until his retirement in March 2019. Prior to joining Omnicell, Mr. Seim served as Chief Financial Officer of several technology companies, including Villa Montage Systems, Inc. from 1999 to 2001, Candera, Inc. from 2001 to 2004 and Mirra, Inc., in 2005. Prior to 1999, Mr. Seim held a number of management positions with Nortel Networks, Bay Networks, and IBM. Mr. Seim received a B.S. in accounting from California State University, Sacramento.
As the Director of Omnicell, the total compensation of Robin Seim at Omnicell is $396,590. There are 9 executives at Omnicell getting paid more, with Randall Lipps having the highest compensation of $7,208,970.
Robin Seim is 60, he's been the Director of Omnicell since 2019. There are 10 older and 9 younger executives at Omnicell. The oldest executive at Omnicell, Inc. is Sara White, 74, who is the Independent Director.
Robin's mailing address filed with the SEC is OMNICELL, INC., 4220 NORTH FREEWAY, FORT WORTH, TX, 76137.
Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps y Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
Omnicell executives and other stock owners filed with the SEC include: